Overexpression of OAS1 is correlated with poor prognosis in pancreatic cancer

L Lu, H Wang, J Fang, J Zheng, B Liu, L Xia… - Frontiers in …, 2022 - frontiersin.org
Background OAS1 expression in pancreatic cancer has been confirmed by many studies.
However, the prognostic value and mechanism of OAS1 in pancreatic cancer have not been …

Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy

L Wang, D Fu, S Weng, H Xu, L Liu, C Guo, Y Ren… - Cellular …, 2023 - Elsevier
Pancreatic cancer (PC) was featured by dramatic heterogeneity and dismal outcomes. An
ideal classification strategy capable of achieving risk stratification and individualized …

[HTML][HTML] Oncolytic activity of wild-type Newcastle disease virus HK84 against hepatocellular carcinoma associated with activation of type I interferon signaling

L Chen, Y Niu, J Sun, H Lin, G Liang… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Methods Cell proliferation and apoptosis were determined by cell counting Kit-8 and
fluorescein isothiocyanate Annexin V apoptosis assays. Colony formation, wound healing …

BDNF Acts as a Prognostic Factor Associated with Tumor‐Infiltrating Th2 Cells in Pancreatic Adenocarcinoma

Y Zhu, C Zhang, D Zhao, W Li, Z Zhao, S Yao… - Disease …, 2021 - Wiley Online Library
Pancreatic adenocarcinoma (PAAD) is an extremely lethal disease worldwide. Brain‐
derived neurotrophic factor (BDNF) is a critical member of the neurotrophin polypeptide …

Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer

B Liu, T Fu, P He, C Du, K Xu - Bioscience Reports, 2021 - portlandpress.com
Purpose: To identify differentially expressed immune-related genes (DEIRGs) and construct
a model with survival-related DEIRGs for evaluating the prognosis of patients with …

Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma

X Li, N Qiu, Q Li - Frontiers in Genetics, 2021 - frontiersin.org
Objective: Pancreatic adenocarcinoma (PAAD) is a common malignant tumor worldwide.
S100 family (S100s) is wildly involved in regulating the occurrence, development, invasion …

Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer

W Zou, L Li, Z Wang, N Jiang, F Wang, M Hu… - Bioengineered, 2021 - Taylor & Francis
Pancreatic cancer is associated with a high mortality rate, and the prognosis is positively
related to immune status. In this study, we constructed a prognostic signature from survival …

Construction of immune-related gene pairs signature to predict the overall survival of multiple myeloma patients based on whole bone marrow gene expression …

F Jafari-Raddani, Z Davoodi-Moghaddam… - Molecular Genetics and …, 2024 - Springer
Multiple myeloma (MM) is a plasma cell dyscrasia that is characterized by the uncontrolled
proliferation of malignant PCs in the bone marrow. Due to immunotherapy, attention has …

Gene Expression Profiling Regulated by lncRNA H19 Using Bioinformatic Analyses in Glioma Cell Lines

Y Chae, J Roh, M Im, W Jang, B Kim… - Cancer Genomics & …, 2024 - cgp.iiarjournals.org
Background/Aim: Glioma, the most common type of primary brain tumor, is characterized by
high malignancy, recurrence, and mortality. Long non-coding RNA (lncRNA) H19 is a …

Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling

Q Chen, LY Jiang, C Cao, FY Liu, DR Li… - Molecular …, 2024 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is a highly invasive cancer with a poor prognosis
and a 5‐year survival rate of less than 11%. As a member of the CAP superfamily of …